Relationship between Left Ventricular Outflow Tract Pressure Gradient and Hemoglobin in Patients with Hypertrophic

Yangyi Lin1, Lisha Yu2, Fangfei Liu3

  • 1Department of Cardiology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences.

Insights

Lower hemoglobin levels are linked to increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients. This finding suggests hemoglobin can help predict obstruction severity in hypertrophic obstructive cardiomyopathy.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Hematology

Background:

  • Anemia association with left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy (HOCM) is suggested but lacks large-scale clinical validation.
  • Hypertrophic cardiomyopathy (HCM) is a condition affecting the heart muscle, potentially leading to obstruction of blood flow out of the left ventricle.

Purpose of the Study:

  • To investigate the relationship between left ventricular outflow tract (LVOT) pressure gradient and hemoglobin levels in patients diagnosed with hypertrophic cardiomyopathy (HCM).
  • To determine if hemoglobin levels can serve as a predictive marker for LVOT obstruction in HCM patients.

Main Methods:

  • Retrospective analysis of demographic, laboratory, and echocardiography data from 310 HCM patients (July 2014 - March 2019).
  • Patients were categorized into HOCM and non-HOCM groups for comparative analysis.
  • Statistical methods included correlation analysis and receiver operating characteristic (ROC) curve analysis to assess predictive value.

Main Results:

  • Patients with HOCM exhibited significantly lower hemoglobin levels (112.2 g/L) compared to non-HOCM patients (132.9 g/L).
  • A significant inverse correlation was observed between hemoglobin levels and LVOT pressure gradient in both males (r = -0.568) and females (r = -0.589).
  • ROC analysis identified specific hemoglobin cut-off values (128 g/L for males, 125 g/L for females) with notable sensitivity and specificity for predicting HOCM.

Conclusions:

  • Hemoglobin level is inversely proportional to the LVOT pressure gradient in HCM patients.
  • Hemoglobin levels demonstrate predictive value for identifying outflow tract obstruction in patients with hypertrophic cardiomyopathy.
  • These findings support the use of hemoglobin as a potential biomarker for assessing the severity of LVOT obstruction in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
249
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
558
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
232
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
246
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K